Clinical Trial Update: Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating a combination of metaiodobenzylguanidine (MIBG) labeled with iodine-131 and topotecan in young patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• MIBG (metaiodobenzylguanidine) I-131 (metaiodobenzylguanidine (MIBG) labeled with iodine-131)
• Topotecan (topotecan)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Neuroblastoma | Phase 2 | Status: COMPLETED